Search

Your search keyword '"Kerenyi, Z."' showing total 33 results

Search Constraints

Start Over You searched for: Author "Kerenyi, Z." Remove constraint Author: "Kerenyi, Z."
33 results on '"Kerenyi, Z."'

Search Results

2. Dapagliflozin and cardiovascular outcomes in type 2 diabetes

3. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

7. Molecular standardization of mating type terminology in the Gibberella fujikuroi species complex

9. Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes

10. Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

11. Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study

12. Repeatability of three-day dietary records in the EURODIAB IDDM Complications Study

13. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

14. Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes

15. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria

16. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study

17. Nutritional intake of 2868 IDDM patients from 30 centres in Europe

18. Cardiovascular disease and its risk factors in IDDM in Europe

19. BLOOD-PRESSURE, RETINOPATHY AND URINARY ALBUMIN EXCRETION IN IDDM - THE EURODIAB IDDM COMPLICATIONS STUDY

20. The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study

21. Consensus guidelines for the management of insulin-dependent (TYPE 1) diabetes

22. Different risk factors of microangiopathy in patients with Type I diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study

26. Retinopathy and Vision Loss in Insulin-dependent Diabetes in Europe

27. The DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: Baseline characteristics

28. 40 EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

29. Retinopathy and Vision Loss in Insulin-dependent Diabetes in Europe: The EURODIAB IDDM Complications Study

30. Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

31. Nectar- and stigma exudate-specific expression of an acidic chitinase could partially protect certain apple cultivars against fire blight disease.

32. Combination therapy with rosiglitazone and glibenclamide compared with upward titration of glibenclamide alone in patients with type 2 diabetes mellitus.

33. Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes.

Catalog

Books, media, physical & digital resources